EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age ; volume:57 ; number:4 ; day:4 ; month:3 ; year:2023 ; pages:656-661 ; date:7.2023
Therapeutic innovation & regulatory science ; 57, Heft 4 (4.3.2023), 656-661, 7.2023
- Creator
-
Thor, Shannon
Vetter, Thorsten
Marcal, Anabela
Kweder, Sandra
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-023-00501-9
- URN
-
urn:nbn:de:101:1-2023092208061082095906
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thor, Shannon
- Vetter, Thorsten
- Marcal, Anabela
- Kweder, Sandra
- SpringerLink (Online service)
Other Objects (12)
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations
FDA
FDA
FDA
FDA
Ema: Ema in Sakuraform
DNA einer Stadt : Hannovers Bewerbung als neuer Standort für die European Medicines Agency (EMA)
Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
Ema: Schatzschiff (宝船の絵馬Takarabune no ema)
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations
FDA
FDA
FDA
FDA
Ema: Ema in Sakuraform
DNA einer Stadt : Hannovers Bewerbung als neuer Standort für die European Medicines Agency (EMA)
Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
Ema: Schatzschiff (宝船の絵馬Takarabune no ema)
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations
FDA
FDA
FDA
FDA
Ema: Ema in Sakuraform
DNA einer Stadt : Hannovers Bewerbung als neuer Standort für die European Medicines Agency (EMA)
Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
Ema: Schatzschiff (宝船の絵馬Takarabune no ema)